epirubicin has been researched along with prednimustine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heydarfadai, M; Lahousen, M; Petru, E; Pickel, H | 1 |
| Arian-Schad, K; Hackl, A; Heydarfadai, M; Lahousen, M; Petru, E; Pickel, H; Stettner, H | 1 |
| Boike, G; Heydarfadai, M; Lahousen, M; Petru, E; Pickel, H | 1 |
| Fridrik, M; Hausmaninger, H; Hehenwarter, W; Lehnert, M; Manfreda, D; Michlmayr, G; Samonigg, H; Schiller, L; Sevelda, P; Steger, G | 1 |
| Pickel, H | 1 |
| Aapro, MS; Alberto, P; Forni, M; Krauer, F; Wählby, S | 1 |
| Chiba, T; Fujioka, T; Hiura, M; Murakami, J; Nogawa, T; Shigemasa, K; Shimokawa, T; Yokoyama, T | 1 |
| Chuchkova, M; Damianov, C; Koleva, P; Terziev, T | 1 |
| Hackl, A; Kapp, K; Lahousen, M; Petru, E; Pickel, H; Stettner, H; Winter, R | 1 |
3 trial(s) available for epirubicin and prednimustine
| Article | Year |
|---|---|
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Germany, West; Humans; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Metastasis; Prednimustine; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 1989 |
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Prednimustine; Radiotherapy, Adjuvant; Survival Rate | 1999 |
6 other study(ies) available for epirubicin and prednimustine
| Article | Year |
|---|---|
Remission induction with carboplatin-epirubicin-prednimustine followed by consolidation radiotherapy in advanced ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Epirubicin; Female; Humans; Lymphatic Irradiation; Ovarian Neoplasms; Prednimustine; Remission Induction | 1992 |
Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Hematologic Diseases; Humans; Neoplasm Staging; Ovarian Neoplasms; Pilot Projects; Prednimustine; Survival Rate | 1991 |
Combination chemotherapy in radically operated advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Hysterectomy; Life Tables; Lymph Node Excision; Middle Aged; Ovarian Neoplasms; Ovariectomy; Prednimustine; Survival Rate | 1990 |
[Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Hysterectomy; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Prednimustine; Retrospective Studies | 1989 |
Preliminary analysis of combined treatment with prednimustine and 4'epidoxorubicin in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Prednimustine | 1986 |
[Study on peripheral blood stem cells mobilized by different chemotherapies with granulocyte-colony stimulating factor in ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Ovarian Neoplasms; Prednimustine | 1995 |